+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Insomnia Therapeutics Market Size, Share & Trends Analysis Report by Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists), Sales Channel, and Region with Growth Forecasts, 2025-2030- Product Image
Insomnia Therapeutics Market Size, Share & Trends Analysis Report by Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists), Sales Channel, and Region with Growth Forecasts, 2025-2030- Product Image
New

Insomnia Therapeutics Market Size, Share & Trends Analysis Report by Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists), Sales Channel, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 5998674
Description Jump to:
The Insomnia Therapeutics Market was valued at USD 2.89 billion in 2024, and is projected to reach USD 3.74 billion by 2030, rising at a CAGR of 4.50%. The market is primarily driven by the presence of patented molecules, potential clinical pipeline candidates, rising stress level, and increase in geriatric population who find it difficult to fall asleep. Increase in prevalence of insomnia & awareness about this condition and availability of safer drugs are anticipated to fuel revenue growth.

Insomnia is estimated to affect approximately 35% of the global population. Different patterns of the condition include difficulty in sleep initiation and maintenance, which is generally accompanied with frequent awakenings & awakening too early with trouble sleeping again. Long-term insomnia can hamper everyday life, which may result in nonproductive work hours. If left untreated, this condition may lead to severe depression and nervous breakdown of the patient.

Factors influencing insomnia therapeutics market growth include rising stress level, presence of patented molecules in the market, potential drugs in clinical pipeline, introduction of technologically advanced medical devices, and growing geriatric population. Growing awareness about the impact of sleep deprivation on everyday life is anticipated to increase adoption rate of various treatments for insomnia, which is expected to lead to revenue growth of the insomnia therapeutics market.

Currently, widely adopted treatment options for insomnia include generic nonbenzodiazepines and antidepressants even though other novel agents such as orexin antagonists and melatonin antagonists are available in the market. Launch of Eisai’s Lemborexant is expected to cater to unmet medical needs in this segment and fuel growth of this market over the forecast period. According to United Nations (UN) report in 2015, population in the age group of 60 years and above is projected to grow by 56% and is expected to reach around 1.4 billion by 2030. These statistics indicate the growing geriatric population. Since this population base is more susceptible to sleep deprivation, the demand for insomnia therapeutics is anticipated to increase.

Insomnia Therapeutics Market Report Highlights

  • Benzodiazepines dominated the market and accounted for a share of 29.1% in 2024. Benzodiazepines are useful for insomnia associated with acute stress. Antidepressants are expected to grow lucratively over the forecast period.
  • Over-the-counter (OTC) led the market and accounted for a share of 61.6% in 2024, owing to the increasing number of patients with insomnia. Prescription therapeutics are projected to grow rapidly over the forecast period, fueled by the increasing awareness regarding drugs and their consumption amongst people.
  • North America insomnia therapeutics market dominated the global market with a revenue share of 35.4% in 2024. Market growth in the region is due to the rising incidence of insomnia disorders, the increase in awareness levels, and high healthcare spending in this region.
  • Asia Pacific insomnia therapeutics market is expected to register the fastest CAGR of 5.3% in the forecast period. Asia Pacific insomnia therapeutics market is anticipated to witness significant growth in the insomnia therapeutics market.

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Sales Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Insomnia Therapeutics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Insomnia Therapeutics Market: Type Business Analysis
4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Benzodiazepines
4.4.1. Benzodiazepines Market, 2018-2030 (USD Million)
4.5. Nonbenzodiazepines
4.5.1. Nonbenzodiazepines Market, 2018-2030 (USD Million)
4.6. Antidepressants
4.6.1. Antidepressants Market, 2018-2030 (USD Million)
4.7. Orexin Antagonists
4.7.1. Orexin Antagonists Market, 2018-2030 (USD Million)
4.8. Melatonin Antagonists
4.8.1. Melatonin Antagonists Market, 2018-2030 (USD Million)
4.9. Others
4.9.1. Others Market, 2018-2030 (USD Million)
Chapter 5. Insomnia Therapeutics Market: Sales Channel Business Analysis
5.1. Sales Channel Market Share, 2024 & 2030
5.2. Sales Channel Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Sales Channel, 2018 to 2030 (USD Million)
5.4. Prescription
5.4.1. Prescription Market, 2018-2030 (USD Million)
5.5. Over-the-Counter (OTC)
5.5.1. Over-the-Counter (OTC) Market, 2018-2030 (USD Million)
Chapter 6. Insomnia Therapeutics Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Insomnia Therapeutics Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5. Europe
6.5.1. Europe Insomnia Therapeutics Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5.7. Norway
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Norway Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Denmark Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key Country Dynamics
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Sweden Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Insomnia Therapeutics Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. South Korea Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. Australia Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Insomnia Therapeutics Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.8. MEA
6.8.1. MEA Insomnia Therapeutics Market Estimates And Forecasts, by Country, 2018-2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Insomnia Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Takeda Pharmaceutical Company Limited
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. VANDA PHARMACEUTICALS
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Merck & Co., Inc.
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Pfizer Inc.
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Teva Pharmaceutical Industries Ltd.
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Mylan N.V. (Viatris Inc.)
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Sumitomo Pharma Co., Ltd.
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Sanofi
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Paratek Pharmaceuticals, Inc.
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. Ebb Therapeutics (Kryo)
7.5.10.1. Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global insomnia therapeutics market, by region, 2018-2030 (USD Million)
Table 4. Global insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 5. Global insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 6. North America insomnia therapeutics market, by country, 2018-2030 (USD Million)
Table 7. North America insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 8. North America insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 9. U.S. insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 10. U.S. Insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 11. Canada insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 12. Canada insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 13. Mexico insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 14. Mexico insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 15. Europe insomnia therapeutics market, by country, 2018-2030 (USD Million)
Table 16. Europe insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 17. Europe insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 18. UK insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 19. UK Insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 20. Germany insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 21. Germany insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 22. France insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 23. France Insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 24. Italy insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 25. Italy insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 26. Spain insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 27. Spain insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 28. Norway insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 29. Norway Insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 30. Denmark insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 31. Denmark insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 32. Sweden insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 33. Sweden insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 34. Asia Pacific insomnia therapeutics market, by country, 2018-2030 (USD Million)
Table 35. Asia Pacific insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 36. Asia Pacific insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 37. Japan insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 38. Japan insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 39. China insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 40. China insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 41. India insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 42. India insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 43. Australia insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 44. Australia insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 45. South Korea insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 46. South Korea insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 47. Thailand insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 48. Thailand insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 49. Latin America insomnia therapeutics market, by country, 2018-2030 (USD Million)
Table 50. Latin America insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 51. Latin America insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 52. Brazil insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 53. Brazil insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 54. Argentina insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 55. Argentina insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 56. Middle East & Africa Insomnia therapeutics market, by country, 2018-2030 (USD Million)
Table 57. Middle East & Africa insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 58. Middle East & Africa insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 59. South Africa insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 60. South Africa insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 61. Saudi Arabia insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 62. Saudi Arabia insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 63. UAE insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 64. UAE insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
Table 65. Kuwait insomnia therapeutics market, by type, 2018-2030 (USD Million)
Table 66. Kuwait insomnia therapeutics market, by sales channel, 2018-2030 (USD Million)
List of Figures
Figure 1 Insomnia therapeutics market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Type and sales channel outlook (USD Million)
Figure 10 Competitive landscape
Figure 11 Insomnia therapeutics market dynamics
Figure 12 Insomnia therapeutics market: Porter’s five forces analysis
Figure 13 Insomnia therapeutics market: PESTLE analysis
Figure 14 Insomnia therapeutics market: Type segment dashboard
Figure 15 Insomnia therapeutics market: Type market share analysis, 2024 & 2030
Figure 16 Benzodiazepines market, 2018-2030 (USD Million)
Figure 17 Nonbenzodiazepines market, 2018-2030 (USD Million)
Figure 18 Antidepressants market, 2018-2030 (USD Million)
Figure 19 Orexin antagonists market, 2018-2030 (USD Million)
Figure 20 Melatonin antagonists market, 2018-2030 (USD Million)
Figure 21 Others market, 2018-2030 (USD Million)
Figure 22 Insomnia therapeutics market: Sales channel segment dashboard
Figure 23 Insomnia therapeutics market: Sales channel market share analysis, 2024 & 2030
Figure 24 Prescription market, 2018-2030 (USD Million)
Figure 25 Over-the-counter (OTC) market, 2018-2030 (USD Million)
Figure 26 Insomnia therapeutics market revenue, by region
Figure 27 Regional marketplace: Key takeaways
Figure 28 Regional marketplace: Key takeaways
Figure 29 North America insomnia therapeutics market, 2018-2030 (USD Million)
Figure 30 U.S. country dynamics
Figure 31 U.S. insomnia therapeutics market, 2018-2030 (USD Million)
Figure 32 Canada country dynamics
Figure 33 Canada insomnia therapeutics market, 2018-2030 (USD Million)
Figure 34 Mexico country dynamics
Figure 35 Mexico insomnia therapeutics market, 2018-2030 (USD Million)
Figure 36 Europe insomnia therapeutics market, 2018-2030 (USD Million)
Figure 37 UK country dynamics
Figure 38 UK insomnia therapeutics market, 2018-2030 (USD Million)
Figure 39 Germany country dynamics
Figure 40 Germany insomnia therapeutics market, 2018-2030 (USD Million)
Figure 41 France country dynamics
Figure 42 France insomnia therapeutics market, 2018-2030 (USD Million)
Figure 43 Italy country dynamics
Figure 44 Italy insomnia therapeutics market, 2018-2030 (USD Million)
Figure 45 Spain country dynamics
Figure 46 Spain insomnia therapeutics market, 2018-2030 (USD Million)
Figure 47 Norway country dynamics
Figure 48 Norway insomnia therapeutics market, 2018-2030 (USD Million)
Figure 49 Sweden country dynamics
Figure 50 Sweden insomnia therapeutics market, 2018-2030 (USD Million)
Figure 51 Denmark country dynamics
Figure 52 Denmark insomnia therapeutics market, 2018-2030 (USD Million)
Figure 53 Asia Pacific insomnia therapeutics market, 2018-2030 (USD Million)
Figure 54 Japan country dynamics
Figure 55 Japan insomnia therapeutics market, 2018-2030 (USD Million)
Figure 56 China country dynamics
Figure 57 China insomnia therapeutics market, 2018-2030 (USD Million)
Figure 58 India country dynamics
Figure 59 India insomnia therapeutics market, 2018-2030 (USD Million)
Figure 60 Australia country dynamics
Figure 61 Australia insomnia therapeutics market, 2018-2030 (USD Million)
Figure 62 South Korea country dynamics
Figure 63 South Korea insomnia therapeutics market, 2018-2030 (USD Million)
Figure 64 Thailand country dynamics
Figure 65 Thailand insomnia therapeutics market, 2018-2030 (USD Million)
Figure 66 Latin America insomnia therapeutics market, 2018-2030 (USD Million)
Figure 67 Brazil country dynamics
Figure 68 Brazil insomnia therapeutics market, 2018-2030 (USD Million)
Figure 69 Argentina country dynamics
Figure 70 Argentina insomnia therapeutics market, 2018-2030 (USD Million)
Figure 71 MEA insomnia therapeutics market, 2018-2030 (USD Million)
Figure 72 South Africa country dynamics
Figure 73 South Africa insomnia therapeutics market, 2018-2030 (USD Million)
Figure 74 Saudi Arabia country dynamics
Figure 75 Saudi Arabia insomnia therapeutics market, 2018-2030 (USD Million)
Figure 76 UAE country dynamics
Figure 77 UAE insomnia therapeutics market, 2018-2030 (USD Million)
Figure 78 Kuwait country dynamics
Figure 79 Kuwait insomnia therapeutics market, 2018-2030 (USD Million)
Figure 80 Company categorization
Figure 81 Company market position analysis
Figure 82 Strategic framework

Companies Mentioned

The major companies profiled in this Insomnia Therapeutics market report include:
  • Takeda Pharmaceutical Company Limited
  • VANDA PHARMACEUTICALS
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V. (Viatris Inc.)
  • Sumitomo Pharma Co., Ltd.
  • Sanofi
  • Paratek Pharmaceuticals, Inc.
  • Ebb Therapeutics (Kryo)

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.89 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.74 Billion
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Insomnia Drugs Market by Type, Distribution Channels - Global Forecast 2025-2030 - Product Image

Insomnia Drugs Market by Type, Distribution Channels - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Insomnia Therapeutics Market 2024-2028 - Product Image

Insomnia Therapeutics Market 2024-2028

  • Report
  • 156 Pages
  • Global
From
Chronic Insomnia - Pipeline Insight, 2024 - Product Image

Chronic Insomnia - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Insomnia - Pipeline Insight, 2024 - Product Image

Insomnia - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From
Insomnia Drugs - Global Strategic Business Report - Product Image

Insomnia Drugs - Global Strategic Business Report

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.